» Articles » PMID: 32815984

Association of Industry Sponsorship With Cancer Clinical Trial Accrual

Overview
Journal JAMA Oncol
Specialty Oncology
Date 2020 Aug 21
PMID 32815984
Citations 7
Authors
Affiliations
Soon will be listed here.
Citing Articles

Improving drug repositioning with negative data labeling using large language models.

Picard M, Leclercq M, Bodein A, Scott-Boyer M, Perin O, Droit A J Cheminform. 2025; 17(1):16.

PMID: 39905466 PMC: 11796214. DOI: 10.1186/s13321-025-00962-0.


Towards Treatment Effect Interpretability: A Bayesian Re-analysis of 194,129 Patient Outcomes Across 230 Oncology Trials.

Sherry A, Msaouel P, Kupferman G, Lin T, Abi Jaoude J, Kouzy R medRxiv. 2024; .

PMID: 39108512 PMC: 11302607. DOI: 10.1101/2024.07.23.24310891.


Text Classification of Cancer Clinical Trial Eligibility Criteria.

Yang Y, Jayaraj S, Ludmir E, Roberts K AMIA Annu Symp Proc. 2024; 2023:1304-1313.

PMID: 38222417 PMC: 10785908.


Prevalence, trends, and characteristics of trials investigating local therapy in contemporary phase 3 clinical cancer research.

Sherry A, Corrigan K, Kouzy R, Abi Jaoude J, Yang Y, Patel R Cancer. 2023; 129(21):3430-3438.

PMID: 37382235 PMC: 11349322. DOI: 10.1002/cncr.34929.


Prostate cancer clinical trial completion: The role of geography.

Stensland K, Kaffenberger S, George A, Morgan T, Miller D, Salami S Contemp Clin Trials. 2021; 111:106600.

PMID: 34673273 PMC: 8908357. DOI: 10.1016/j.cct.2021.106600.


References
1.
Stensland K, McBride R, Latif A, Wisnivesky J, Hendricks R, Roper N . Adult cancer clinical trials that fail to complete: an epidemic?. J Natl Cancer Inst. 2014; 106(9). DOI: 10.1093/jnci/dju229. View

2.
Chopra S . MSJAMA: Industry funding of clinical trials: benefit or bias?. JAMA. 2003; 290(1):113-4. DOI: 10.1001/jama.290.1.113. View

3.
Bennette C, Ramsey S, McDermott C, Carlson J, Basu A, Veenstra D . Predicting Low Accrual in the National Cancer Institute's Cooperative Group Clinical Trials. J Natl Cancer Inst. 2015; 108(2). PMC: 5964887. DOI: 10.1093/jnci/djv324. View

4.
Gelijns A, Thier S . Medical innovation and institutional interdependence: rethinking university-industry connections. JAMA. 2002; 287(1):72-7. DOI: 10.1001/jama.287.1.72. View

5.
Booth C, Cescon D, Wang L, Tannock I, Krzyzanowska M . Evolution of the randomized controlled trial in oncology over three decades. J Clin Oncol. 2008; 26(33):5458-64. PMC: 2651075. DOI: 10.1200/JCO.2008.16.5456. View